PATENT CLAIM ANALYSIS

Application Number: 16420544
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-09
Patent Classification: ["514", "278000"]

Abstract:
The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating MAGL-mediated diseases and disorders including, e.g., pain, an inflammatory disorder, depression, anxiety, Alzheimer's disease, a metabolic disorder, stroke, or cancer.

Claim (Index 15):
The method of  claim 6 , wherein R 2A  is \u2014NR 3 S(\u2550O) 2 R 4  or \u2014NR 3 C(\u2550O)R 4 ; .R 3  is methyl; each R 4  is independently selected from the group consisting of C 1-6  alkyl, C 3-7  cycloalkyl, (C 3-7  cycloalkyl)-C 1-2  alkyl-, (phenyl)-C 1-2  alkyl-, and phenyl.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 100.0
- Lexical Diversity: 1.52
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15874987', '15221658', '15808242', '14652150', '14902324']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8354588907314334
- 35 USC 102 Novelty (BERT): 0.5946704732776575
- Combined Prediction Score: 0.8113800489860559
- Mean Citation Score: 395.616206
- Max Citation Score: 519.7040400000002
- Similarity Product: 461.4800323343612

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test